Clinical Trials Search
Clinical Trial 20641
Cancer Type: Cutaneous
Study Type: Treatment
NCT#: NCT04741997
Phase: N/A
Prinicipal Investigator: Zeynep Eroglu
Study Title
A Randomized Pilot Trial of Adjuvant Therapy Based on Pathologic Response After Neoadjuvant Encorafenib and Binimetinib in Advanced Melanoma
Summary
The purpose of this study is to assess rate of disease relapse and hazard rate of disease relapse after neoadjuvant therapy based on the statuses of pathologic complete response or non-pathologic complete response, and postoperative adjuvant therapy.
Objective
2.1 PRIMARY OBJECTIVE To estimate the rate of disease relapse and hazard rate after neoadjuvant therapy based on the statuses of pathologic CR or non-pCR, and postoperative adjuvant therapy.
Therapies
Medications
BMS-936558 (Nivolumab); Binimetinib (); Encorafenib (); Nivolumab (Opdivo); Not Applicable ()
If you are interested in learning more about clinical trials, our clinical trial navigators can discuss your options and recommend opportunities that may be suitable for you. Call 813-745-6100 or 1-800-679-0775 (toll-free) or submit a clinical trials inquiry form.